Whitney & Co’s Rentokil RTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.01M Buy
209,923
+7,225
+4% +$229K 0.44% 54
2026
Q1
$6.38M Sell
202,698
-1,727
-0.8% -$54.4K 0.53% 52
2025
Q4
$6.02M Sell
204,425
-22,453
-10% -$624K 0.48% 52
2025
Q3
$5.73M Sell
226,878
-3,157
-1% -$76.9K 0.52% 56
2025
Q2
$5.52M Buy
230,035
+1,338
+0.6% +$31K 0.54% 55
2025
Q1
$5.24M Buy
228,697
+11,236
+5% +$271K 0.56% 57
2024
Q4
$5.51M Buy
217,461
+8,084
+4% +$205K 0.58% 51
2024
Q3
$5.22M Buy
209,377
+6,401
+3% +$190K 0.56% 51
2024
Q2
$6.02M Buy
202,976
+43,041
+27% +$1.19M 0.69% 47
2024
Q1
$4.82M Buy
+159,935
New +$4.44M 0.57% 52

Other funds holding RTO

Whitney & Co's RTO Position: Q2 2026 in Review

Whitney & Co increased its Rentokil (RTO) stake by 3.6% in Q2 2026, buying an estimated $229K and bringing the position to 209,923 shares worth $6.01M. The position accounts for 0.44% of the portfolio, ranked #54.

Whitney & Co first reported a position in RTO in Q1 2024 and has held it in 10 quarters since. The position peaked at $6.38M in Q1 2026. 83 funds tracked by Wall St. Rank hold RTO as of Q2 2026.

  • Whitney & Co held 209,923 shares of Rentokil worth $6.01M as of Q2 2026.
  • Whitney & Co bought 7,225 Rentokil shares in Q2 2026, an estimated $229K.
  • Rentokil made up 0.44% of Whitney & Co's portfolio in Q2 2026, its #54 holding.
  • Whitney & Co first reported a position in Rentokil in Q1 2024 and has held it in 10 quarters since.
  • Whitney & Co's Rentokil position peaked at $6.38M in Q1 2026.
  • 83 funds tracked by Wall St. Rank held Rentokil as of Q2 2026.

Based on Whitney & Co's 13F filing for Q2 2026, filed 28 Jul 2026.